Warburg Pincus to invest upto USD 125 million in Stellar Value Chain Solutions
Aug 04, 2016: Stellar Value Chain Solutions, a third party logistics company serving consumption driven sectors in India, announced that an affiliate of Warburg Pincus, a global private equity firm focused on growth investing, has agreed to invest up to USD 125 million in the company.
Anshuman Singh, founder and CEO, Stellar Value Chain Solutions, commented, “This is a very exciting stage for the USD130 billion Indian logistics and warehousing industry, which is rapidly transforming and growing whilst also offering a number of consolidation opportunities. Over the next few years, we are looking to provide integrated logistics solutions which will include modern distribution centres and warehousing facilities at strategic locations across India. Our solutions will help customers realign their supply chain networks and unlock value, especially following the implementation of GST.”
Viraj Sawhney, managing director at Warburg Pincus, said, “We believe there is a shortage of high quality providers of outsourced logistics services such as warehouse management and distribution to a wide range of sectors in India. We are excited to partner with Anshuman, and look forward to building Stellar Value Chain Solutions into a world class logistics company with a strong focus on technology and customer satisfaction. We will also seek to drive further consolidation of the third party logistics sector in India through this platform.”
Stellar is looking to serve a large and growing logistics market in India. The company intends to provide integrated logistics solutions that will include multi-user modern warehousing, primary and secondary distribution, e-fulfilment and cold storage.
Stellar will enable value creation for its customers across the supply chain through a strong focus on technology and automation. The company will serve customers in the Food & Beverages, Fast Moving Consumer Goods, Consumer Durables, Electronics & Hi-tech, Lifestyle, Automotive, Pharmaceuticals and Engineering industries.
